Advertisement
Screener

ENVOY MEDICAL, INC. (COCH) Deferred Income Tax Expense (Benefit)

1.4 / 5 stars · 11/38 Roast Me

ENVOY MEDICAL, INC. Deferred Income Tax Expense (Benefit)

ENVOY MEDICAL, INC. (COCH) reported Deferred Income Tax Expense (Benefit) of $2.58 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.

Financial Statements › Cash Flow › Operating Activities

us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2025-03-31

  • ENVOY MEDICAL, INC. deferred income tax expense (benefit) for fiscal 2024 was $2.58M, a 55.25% decline from fiscal 2023.
  • ENVOY MEDICAL, INC. deferred income tax expense (benefit) for fiscal 2023 was $5.78M, a 795.50% increase from fiscal 2022.
  • ENVOY MEDICAL, INC. deferred income tax expense (benefit) for fiscal 2022 was $645.00K.
Period endDeferred Income Tax Expense (Benefit) 12 month
2024-12-31$2.58M
10-K · filed 2025-03-31
2023-12-31$5.78M
10-K · filed 2025-03-31
2022-12-31$645.00K
10-K · filed 2024-04-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
ALPHA PRO TECH LTD (APT)$0.052B13.63
MYOMO, INC. (MYO)United States$0.065B-2.85
MILESTONE SCIENTIFIC INC. (MLSS)United States$0.036B-6.85
Safe Pro Group Inc. (SPAI)United States$0.090B
Lifeward Ltd. (LFWD)$0.021B
ENvue Medical, Inc. (FEED)United States$0.011B
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
NutriBand Inc. (NTRB)United States$0.109B
Bone Biologics Corp (BBLG)United States$0.001B
Conexeu Sciences Inc. (CNXU)United States$0.111B